These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29087163)

  • 21. Dyslipidemia in Patients with Kidney Disease.
    Thobani A; Jacobson TA
    Cardiol Clin; 2021 Aug; 39(3):353-363. PubMed ID: 34247749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of statins in chronic kidney disease.
    Kalaitzidis RG; Elisaf MS
    Am J Nephrol; 2011; 34(3):195-202. PubMed ID: 21791915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lowering cholesterol in chronic kidney disease: is it safe and effective?
    Wong MG; Wanner C; Knight J; Perkovic V
    Eur Heart J; 2015 Nov; 36(43):2988-95. PubMed ID: 26289904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin use in patients with diabetes and kidney disease: the Japanese experience.
    Koya D; Campese VM
    J Atheroscler Thromb; 2013; 20(5):407-24. PubMed ID: 23518468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of statin therapy on cerebrovascular and renal outcomes in patients with predialysis advanced chronic kidney disease and dyslipidemia.
    Chung CM; Lin MS; Hsu JT; Hsiao JF; Chang ST; Pan KL; Lin CL; Lin YS
    J Clin Lipidol; 2017; 11(2):422-431.e2. PubMed ID: 28502499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary and Secondary Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease.
    Ali S; Dave N; Virani SS; Navaneethan SD
    Curr Atheroscler Rep; 2019 Jun; 21(9):32. PubMed ID: 31230129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular disease in patients with renal disease: the role of statins.
    Fellström B; Holdaas H; Jardine AG; Svensson MK; Gottlow M; Schmieder RE; Zannad F;
    Curr Med Res Opin; 2009 Jan; 25(1):271-85. PubMed ID: 19210158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statins in chronic kidney disease: what do meta-analyses tell us?
    Upadhyay A
    Clin Exp Nephrol; 2014 Apr; 18(2):278-81. PubMed ID: 24158229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Statins and kidney disease].
    Bigazzi R; Grimaldi D; Bianchi S
    G Ital Nefrol; 2012; 29(2):160-73. PubMed ID: 22538946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chronic kidney disease and dyslipidaemia].
    Pascual V; Serrano A; Pedro-Botet J; Ascaso J; Barrios V; Millán J; Pintó X; Cases A
    Clin Investig Arterioscler; 2017; 29(1):22-35. PubMed ID: 27863896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dyslipidemia in patients with chronic kidney disease.
    Hager MR; Narla AD; Tannock LR
    Rev Endocr Metab Disord; 2017 Mar; 18(1):29-40. PubMed ID: 28000009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The lipid story in chronic kidney disease: a long story with a happy end?
    Kujawa-Szewieczek A; Więcek A; Piecha G
    Int Urol Nephrol; 2013 Oct; 45(5):1273-87. PubMed ID: 23054316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of statins on microalbuminuria, proteinuria, progression of kidney function, and all-cause mortality in patients with non-end stage chronic kidney disease: A meta-analysis.
    Zhang Z; Wu P; Zhang J; Wang S; Zhang G
    Pharmacol Res; 2016 Mar; 105():74-83. PubMed ID: 26776964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dyslipidemia, malnutrition, inflammation, cardiovascular disease and mortality in chronic kidney disease.
    Peev V; Nayer A; Contreras G
    Curr Opin Lipidol; 2014 Feb; 25(1):54-60. PubMed ID: 24345987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dyslipidemia in chronic kidney disease: are statins still indicated in reduction cardiovascular risk in patients on dialysis treatment?
    Scarpioni R; Ricardi M; Melfa L; Cristinelli L
    Cardiovasc Ther; 2010 Dec; 28(6):361-8. PubMed ID: 20553296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants.
    Barylski M; Nikfar S; Mikhailidis DP; Toth PP; Salari P; Ray KK; Pencina MJ; Rizzo M; Rysz J; Abdollahi M; Nicholls SJ; Banach M;
    Pharmacol Res; 2013 Jun; 72():35-44. PubMed ID: 23542730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic kidney disease and statins: improving cardiovascular outcomes.
    Walker DB; Walker TJ; Jacobson TA
    Curr Atheroscler Rep; 2009 Jul; 11(4):301-8. PubMed ID: 19500494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Managing dyslipidemia in chronic kidney disease.
    Harper CR; Jacobson TA
    J Am Coll Cardiol; 2008 Jun; 51(25):2375-84. PubMed ID: 18565393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HMG CoA reductase inhibitors and renoprotection: the weight of the evidence.
    Romayne Kurukulasuriya L; Athappan G; Saab G; Whaley Connell A; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):49-59. PubMed ID: 19124395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.